Tetsuya Abe

3.4k citations
255 papers · 2.3k · 1 hit paper · h-index 23

Impact in

  • Surgery top 2%
    • Esophageal Cancer Research and Treatment
    • Esophageal and GI Pathology
  • Oncology top 5%
    • Pancreatic and Hepatic Oncology Research
    • Cancer-related Molecular Pathways

Papers in

    • Esophageal Cancer Research and Treatment 54
    • Esophageal and GI Pathology 21
    • Gastric Cancer Management and Outcomes 19
    • Lung Cancer Diagnosis and Treatment 11
    • Tracheal and airway disorders 9

Tetsuya Abe

229 papers receiving 2.3k citations

Tetsuya Abe's Hit Papers

A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study. 2022 · 130 citations
1300+1+2Years since publication4080120

Peers

Tetsuya Abe
Comparison fields: 5 of 103
  • Surgery 1.0k
  • Oncology 434
  • Pulmonary and Respiratory Medicine 479
  • Hematology 127
  • Cell Biology 153
Replace Hiroshi Matsuoka with:
Hiroshi Matsuoka Japan
Alexandros Polychronidis Greece
Meredith T. Hull United States
George Gallagher United States
Toyoharu Yokoi Japan
Joé U. Levi United States
R J Polson United Kingdom
M Takahashi Japan
Alexander F. Schaapherder Netherlands
W. Mohr Germany
Tetsuya Abe relative to Hiroshi Matsuoka Japan Hiroshi Matsuoka's profile →
Citations per field
00.5×3.3×
Hiroshi Matsuoka · 1×
Citations per year

Countries citing papers authored by Tetsuya Abe

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Abe more than expected).

Fields of papers citing papers by Tetsuya Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Abe. The network helps show where Tetsuya Abe may publish in the future.

Co-authors

The 25 scholars most cited alongside Tetsuya Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tetsuya Abe Line = papers co-authored together Tetsuya Abe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 255 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2001178
2 2016166
3
A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.
Hit paper breakdown →
2022130
4 202165
5
Development of the biologically active Guglielmi detachable coil for the treatment of cerebral aneurysms. Part II: an experimental study in a swine aneurysm model.
200064
6 201757
7 199950
8
Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer.
201150
9 201449
10 200948
11
Experience with peripheral blood stem cell collection for autografts in children with active cancer.
199245
12 202043
13 199443
14 201334
15 201732
16 201732
17 201327
18 202027
19 199526
20 200926

About Tetsuya Abe

Tetsuya Abe is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 255 papers that have together received 2.3k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (54 papers), Esophageal and GI Pathology (21 papers), Gastric Cancer Management and Outcomes (19 papers), Colorectal Cancer Surgical Treatments (15 papers), Pancreatic and Hepatic Oncology Research (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Congenital Heart Disease Studies (10 papers) and Tracheal and airway disorders (9 papers). The work is most often cited by research in Surgery (1.0k citations), Oncology (434 citations), Pulmonary and Respiratory Medicine (479 citations), Hematology (127 citations) and Cell Biology (153 citations). Tetsuya Abe has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Yasuhiro Shimizu, Yuko Kitagawa, Ken Kato, Koji Komori, Seiji Ito, Masahide Fukaya, Yukihiro Yokoyama, Kenichi Nakamura, Soji Ozawa and Kei Muro. Their work appears in journals such as Journal of Clinical Oncology, Surgery Today, Annals of Surgical Oncology, Esophagus and Journal of Clinical Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact